Steven A. Jablo Joins Medical Cannabis Holdings as Chief Operating Officer

Consumer & Retail Products

Share Tweet

Steven A. Jablo Joins Medical Cannabis Holdings as Chief Operating Officer

International Consolidated Companies (INCC) / 'Medical Cannabis Holdings' Steven A. Jablo Joins Medical Cannabis Holdings as Chief Operating Officer 

Sarasota, FL / ACCESSWIRE / August 15, 2014 / International Consolidated Companies (OTC markets INCC ) / Medical Cannabis Holdings today announced that Steven A. Jablo has been appointed Chief Operating Officer of the company.

Mr. Jablo has a strong background in financial and executive management, bringing to Medical Cannabis Holdings years of experience in human resources consulting to Fortune 500 companies. He has sought, recruited and developed people his entire career and as such his expertise will be instrumental in building Medical Cannabis Holdings’ talent base and organizational structure.

Prior the Joining the Company Mr. Jablo was managing partner at Differential Partners of Chicago and Sarasota recruiting top management positions for banks, insurance, entertainment and ecumenical organizations.  Before Differential, Mr. Jablo was a partner at Boyden Global Executive Search, a principal at Dieckman Associates, director at Corporex Corporation and  founded his own search firm – Jablo Partners. Mr. Jablo began his career in the Xerox Corporation’s fabled Sales Management and Business Incentives program quickly rising to the number two sales performer in the company.

Mr.Jablo’s experience includes senior assignments in virtually every type of business. He has completed executive searches across most business sectors, excels at developing an in depth understanding of his client’s needs, and prides himself on recruiting individuals who also fit "culturally" as well as technically. Through his years working in the manufacturing industry, he has developed expertise in distribution and supply chain management. Mr. Jablo has consulted on management and marketing issues ranging from incentive compensation to organizational structure and product distribution strategies. He also has worked with clients in evaluating and developing the emotional maturity of senior management teams.

Jablo is a graduate of the University of Wisconsin and completed a year of law school at Ohio State. Mr. Jablo’s knowledge and experience will be an asset to the company. According to CEO Antonio Uccello, "We are happy to have Steven here to oversee company operations, manage production timelines, budgets and expenditures.  His immediate focus will be to coordinate and oversee the Company’s filings with OTC Markets resulting in bringing the company’s filing status to ‘current’."

"We are very excited about the team we are assembling.  We feel this team is committed to our corporate mission and it's desire to increase shareholder value!" commented Antonio F. Uccello, III, CEO.

About International Consolidated Companies, Inc. (OTC:INCC) [Medical Cannabis Holdings, Inc.] International Consolidated Companies, Inc. (OTC: INCC) is a publicly traded company focused on acquiring and operating businesses and technologies that will help drive efficiencies in the medical marijuana market.

Forward Looking Statements Except for historical information contained herein, this document contains forward-looking statements within the meaning of Section 21-E of the Securities Exchange Act of 1934.
These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein.

Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's annual reports on Form 10-K and its quarterly reports on Form 10-Q both as filed with the Securities and Exchange Commission, which include the Company's cash flow difficulties and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission.

If you have any questions regarding information in these press releases please contact the company listed in the press release. Our complete disclaimer appears here.

Contact Information:
Davyd Field

[email protected]

International Consolidated Companies, Inc. [Medical Cannabis Holdings, Inc.]

+1 (562) 505-4613

SOURCE: International Consolidated Companies, Inc.
Follow This Company on Accesswire